Inovio Pharmaceuticals
INO • NASDAQ • Stock Fundamentals
Inovio Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jacqueline E. Shea, with a market cap of $103.7M.
Market Cap$103.7M
Employees122.0
CEOJacqueline E. Shea
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 13, 2026 · 15 days agoQ1 2026
View reportNext EarningsAug 12, 2026 · in 2 monthsAfter Market Close · Q2 2026
Financials
Based on Q1 2026 filing
Inovio Pharmaceuticals FAQ
Common questions about Inovio Pharmaceuticals
Inovio Pharmaceuticals (INO) has a market capitalization of $103.7M and trades on NASDAQ.
Inovio Pharmaceuticals has approximately 122 employees.